Brian Grassadonia, the Ecosystem Lead of $XYZ, sold 35,145 shares of the company on 10-08-2025 for an estimated $2,811,600. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.2% of their shares of this class of stock. Following this trade, they now own 535,896 shares of this class of $XYZ stock.
$XYZ Insider Trading Activity
$XYZ insiders have traded $XYZ stock on the open market 48 times in the past 6 months. Of those trades, 0 have been purchases and 48 have been sales.
Here’s a breakdown of recent trading of $XYZ stock by insiders over the last 6 months:
- BRIAN GRASSADONIA (Ecosystem Lead) has made 0 purchases and 6 sales selling 55,733 shares for an estimated $4,350,991.
- AMRITA AHUJA (CFO & COO) has made 0 purchases and 8 sales selling 53,184 shares for an estimated $3,837,703.
- DHANANJAY PRASANNA (Technology Lead) has made 0 purchases and 14 sales selling 40,577 shares for an estimated $2,754,060.
- OWEN BRITTON JENNINGS (Business Lead) has made 0 purchases and 7 sales selling 27,203 shares for an estimated $1,998,152.
- CHRYSTY ESPERANZA (Chief Legal Officer) has made 0 purchases and 4 sales selling 11,921 shares for an estimated $735,154.
- AJMERE DALE (Chief Accounting Officer) has made 0 purchases and 9 sales selling 8,722 shares for an estimated $618,670.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$XYZ Congressional Stock Trading
Members of Congress have traded $XYZ stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $XYZ stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 0 purchases and 2 sales worth up to $100,000 on 05/08, 04/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$XYZ Analyst Ratings
Wall Street analysts have issued reports on $XYZ in the last several months. We have seen 17 firms issue buy ratings on the stock, and 3 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 09/23/2025
- Truist Securities issued a "Sell" rating on 08/21/2025
- Jefferies issued a "Buy" rating on 08/15/2025
- Mizuho issued a "Outperform" rating on 08/14/2025
- Raymond James issued a "Outperform" rating on 08/08/2025
- Compass Point issued a "Sell" rating on 08/08/2025
- RBC Capital issued a "Outperform" rating on 08/08/2025
To track analyst ratings and price targets for $XYZ, check out Quiver Quantitative's $XYZ forecast page.
$XYZ Price Targets
Multiple analysts have issued price targets for $XYZ recently. We have seen 29 analysts offer price targets for $XYZ in the last 6 months, with a median target of $80.0.
Here are some recent targets:
- Joseph Vafi from Canaccord Genuity set a target price of $80.0 on 09/23/2025
- Matthew Coad from Truist Securities set a target price of $70.0 on 08/21/2025
- Trevor Williams from Jefferies set a target price of $90.0 on 08/15/2025
- Dan Dolev from Mizuho set a target price of $88.0 on 08/14/2025
- Paul Golding from Macquarie set a target price of $67.0 on 08/12/2025
- James Faucette from Morgan Stanley set a target price of $77.0 on 08/11/2025
- Patrick Moley from Piper Sandler set a target price of $58.0 on 08/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
